Clinomics (XKRX:352770) Other Stockholders Equity : ₩4,849 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clinomics Other Stockholders Equity?

Clinomics's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₩4,849 Mil.

Clinomics's quarterly Other Stockholders Equity declined from Sep. 2023 (₩5,070 Mil) to Dec. 2023 (₩4,223 Mil) but then increased from Dec. 2023 (₩4,223 Mil) to Mar. 2024 (₩4,849 Mil).

Clinomics's annual Other Stockholders Equity increased from Dec. 2021 (₩3,125 Mil) to Dec. 2022 (₩3,416 Mil) and increased from Dec. 2022 (₩3,416 Mil) to Dec. 2023 (₩4,223 Mil).

Clinomics Other Stockholders Equity Historical Data

The historical data trend for Clinomics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinomics Other Stockholders Equity Chart

Clinomics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

407.53

2,012.02

3,124.74

3,416.25

4,222.60

Clinomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial													4,524.36	4,599.96	5,070.18	4,222.60	4,849.36

Clinomics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Clinomics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Clinomics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinomics (XKRX:352770) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinomics Inc (XKRX:352770) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Unist-Gil, Eonyang-eup, Ulju-gun, Ulsan, KOR, 44919

Website

http://www.clinomics.com

Clinomics Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology.

Clinomics (XKRX:352770) Headlines

No Headlines